Overcoming Hurdles with Scaling Processes Down & Out to Better Manufacture mRNA-Based Vaccines for Personalised Medicine
Time: 12:30 pm
day: Day One
Details:
- Accelerating small scale batch production using different starting DNA sequences to reduce time and cost
- Optimising parameters to enable scaling down of equipment for batch-to-batch production of mRNA vaccines and therapeutics for personalised medicines
- Effectively scaling process development for personalised medicines for larger patient populations, using current process procedures
